Raras
Buscar doenças, sintomas, genes...
Doença de Moyamoya
ORPHA:2573CID-10 · I67.5CID-11 · 8B22.BDOENÇA RARA

A doença de Moyamoya (MMD) é uma arteriopatia intracraniana rara que envolve estenose progressiva da vasculatura cerebral localizada na base do cérebro, causando ataques isquêmicos transitórios ou acidentes vasculares cerebrais.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A doença de Moyamoya (MMD) é uma arteriopatia intracraniana rara que envolve estenose progressiva da vasculatura cerebral localizada na base do cérebro, causando ataques isquêmicos transitórios ou acidentes vasculares cerebrais.

Pesquisas ativas
24 ensaios
59 total registrados no ClinicalTrials.gov
Publicações científicas
5.230 artigos
Último publicado: 2026

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
6.2
Japan
Início
All ages
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: I67.5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
7 sintomas
📏
Crescimento
5 sintomas
😀
Face
5 sintomas
👁️
Olhos
4 sintomas
❤️
Coração
4 sintomas
🦴
Ossos e articulações
3 sintomas

+ 33 sintomas em outras categorias

Características mais comuns

90%prev.
Telangiectasia
Muito frequente (99-80%)
55%prev.
Convulsão
Frequente (79-30%)
55%prev.
Deficiência intelectual
Frequente (79-30%)
55%prev.
Ventriculomegalia
Frequente (79-30%)
55%prev.
Anormalidade da vasculatura cerebral
Frequente (79-30%)
Morfologia anormal das narinas
66sintomas
Muito frequente (1)
Frequente (4)
Sem dados (61)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 66 características clínicas mais associadas, ordenadas por frequência.

Telangiectasia
Muito frequente (99-80%)90%
ConvulsãoSeizure
Frequente (79-30%)55%
Deficiência intelectualIntellectual disability
Frequente (79-30%)55%
VentriculomegaliaVentriculomegaly
Frequente (79-30%)55%
Anormalidade da vasculatura cerebralAbnormality of the cerebral vasculature
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico5.230PubMed
Últimos 10 anos200publicações
Pico2025108 papers
Linha do tempo
2026Hoje · 2026🧪 2006Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

6 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive, Multigenic/multifactorial, X-linked recessive.

DIAPH1Protein diaphanous homolog 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Actin nucleation and elongation factor required for the assembly of F-actin structures, such as actin cables and stress fibers (By similarity). Binds to the barbed end of the actin filament and slows down actin polymerization and depolymerization (By similarity). Required for cytokinesis, and transcriptional activation of the serum response factor (By similarity). DFR proteins couple Rho and Src tyrosine kinase during signaling and the regulation of actin dynamics (By similarity). Functions as a

LOCALIZAÇÃO

Cell membraneCell projection, ruffle membraneCytoplasm, cytoskeletonCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCytoplasm, cytoskeleton, spindleCytoplasmNucleus

VIAS BIOLÓGICAS (8)
ERBB2 Regulates Cell MotilityRHO GTPases Activate ForminsRegulation of MITF-M dependent genes involved in invasionRHOF GTPase cycleRHOD GTPase cycle
MECANISMO DE DOENÇA

Deafness, autosomal dominant 1, with or without thrombocytopenia

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. Patients may have mild thrombocytopenia and enlarged platelets, although most of DFNA1 affected individuals do not have significant bleeding tendencies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
99.8 TPM
Músculo esquelético
95.6 TPM
Pulmão
82.2 TPM
Esôfago - Mucosa
81.2 TPM
Skin Sun Exposed Lower leg
72.3 TPM
OUTRAS DOENÇAS (4)
progressive microcephaly-seizures-cortical blindness-developmental delay syndromeautosomal dominant nonsyndromic hearing loss 1Moyamoya diseaseDIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome
HGNC:2876UniProt:O60610
BRCC3Lys-63-specific deubiquitinase BRCC36Candidate gene tested inTolerante
FUNÇÃO

Metalloprotease that specifically cleaves 'Lys-63'-linked polyubiquitin chains (PubMed:19214193, PubMed:20656690, PubMed:24075985, PubMed:26344097). Does not have activity toward 'Lys-48'-linked polyubiquitin chains (PubMed:19214193, PubMed:20656690, PubMed:24075985, PubMed:26344097). Component of the BRCA1-A complex, a complex that specifically recognizes 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damag

LOCALIZAÇÃO

NucleusCytoplasmCytoplasm, cytoskeleton, spindle pole

VIAS BIOLÓGICAS (5)
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaksMetalloprotease DUBsG2/M DNA damage checkpointProcessing of DNA double-strand break endsNonhomologous End-Joining (NHEJ)
OUTRAS DOENÇAS (1)
moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome
HGNC:24185UniProt:P46736
GUCY1A1Guanylate cyclase soluble subunit alpha-1Disease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (2)
Smooth Muscle ContractionNitric oxide stimulates guanylate cyclase
MECANISMO DE DOENÇA

Moyamoya disease 6 with or without achalasia

A form of Moyamoya disease, a progressive cerebral angiopathy characterized by bilateral intracranial carotid artery stenosis and telangiectatic vessels in the region of the basal ganglia. The abnormal vessels resemble a 'puff of smoke' (moyamoya) on cerebral angiogram. Affected individuals can develop transient ischemic attacks and/or cerebral infarction, and rupture of the collateral vessels can cause intracranial hemorrhage. Hemiplegia of sudden onset and epileptic seizures constitute the prevailing presentation in childhood, while subarachnoid bleeding occurs more frequently in adults. MYMY6 is characterized by severe cerebral angiopathy and onset of severe achalasia in infancy or early childhood.

OUTRAS DOENÇAS (1)
Moyamoya disease with early-onset achalasia
HGNC:4685UniProt:Q02108
ANO1Anoctamin-1Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Calcium-activated chloride channel (CaCC) (PubMed:20056604, PubMed:22178883, PubMed:22946059, PubMed:32487539). Plays a role in transepithelial anion transport and smooth muscle contraction. Required for the normal functioning of the interstitial cells of Cajal (ICCs) which generate electrical pacemaker activity in gastrointestinal smooth muscles. Acts as a major contributor to basal and stimulated chloride conductance in airway epithelial cells and plays an important role in tracheal cartilage

LOCALIZAÇÃO

Apical cell membranePresynapse

VIAS BIOLÓGICAS (2)
Induction of Cell-Cell FusionStimuli-sensing channels
MECANISMO DE DOENÇA

Intestinal dysmotility syndrome

An autosomal recessive disorder characterized by impaired intestinal peristalsis, recurrent episodes of haemorrhagic diarrhea, and distention of intestinal loops. Intestinal and hepatic portal venous gas, dysmorphic features, and developmental delay may also be present.

OUTRAS DOENÇAS (2)
moyamoya disease 7intestinal dysmotility syndrome
HGNC:HGNC:21625UniProt:Q5XXA6
ACTA2Actin, aortic smooth muscleMajor susceptibility factor inAltamente restrito
FUNÇÃO

Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells

LOCALIZAÇÃO

Cytoplasm, cytoskeleton

VIAS BIOLÓGICAS (5)
Regulation of CDH1 FunctionFormation of the dystrophin-glycoprotein complex (DGC)Smooth Muscle ContractionNOTCH4 Intracellular Domain Regulates TranscriptionDevelopmental Lineage of Mammary Gland Myoepithelial Cells
OUTRAS DOENÇAS (5)
multisystemic smooth muscle dysfunction syndromeMoyamoya disease 5aortic aneurysm, familial thoracic 6familial thoracic aortic aneurysm and aortic dissection
HGNC:130UniProt:P62736
RNF213E3 ubiquitin-protein ligase RNF213Major susceptibility factor inTolerante
FUNÇÃO

Atypical E3 ubiquitin ligase that can catalyze ubiquitination of both proteins and lipids, and which is involved in various processes, such as lipid metabolism, angiogenesis and cell-autonomous immunity (PubMed:21799892, PubMed:26126547, PubMed:26278786, PubMed:26766444, PubMed:30705059, PubMed:32139119, PubMed:34012115). Acts as a key immune sensor by catalyzing ubiquitination of the lipid A moiety of bacterial lipopolysaccharide (LPS) via its RZ-type zinc-finger: restricts the proliferation of

LOCALIZAÇÃO

Cytoplasm, cytosolLipid droplet

VIAS BIOLÓGICAS (2)
Antigen processing: Ubiquitination & Proteasome degradationSuppression of apoptosis
MECANISMO DE DOENÇA

Moyamoya disease 2

A progressive cerebral angiopathy characterized by bilateral intracranial carotid artery stenosis and telangiectatic vessels in the region of the basal ganglia. The abnormal vessels resemble a 'puff of smoke' (moyamoya) on cerebral angiogram. Affected individuals can develop transient ischemic attacks and/or cerebral infarction, and rupture of the collateral vessels can cause intracranial hemorrhage. Hemiplegia of sudden onset and epileptic seizures constitute the prevailing presentation in childhood, while subarachnoid bleeding occurs more frequently in adults.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
60.2 TPM
Baço
51.6 TPM
Pulmão
42.2 TPM
Tireoide
36.8 TPM
Nervo tibial
31.6 TPM
OUTRAS DOENÇAS (2)
Moyamoya diseaseMoyamoya disease 2
HGNC:14539UniProt:Q63HN8

Variantes genéticas (ClinVar)

478 variantes patogênicas registradas no ClinVar.

🧬 DIAPH1: NM_005219.5(DIAPH1):c.3149-2A>G ()
🧬 DIAPH1: NM_005219.5(DIAPH1):c.1396+1G>A ()
🧬 DIAPH1: NM_005219.5(DIAPH1):c.118-1G>T ()
🧬 DIAPH1: NM_005219.5(DIAPH1):c.3149-1G>A ()
🧬 DIAPH1: NM_005219.5(DIAPH1):c.3410A>G (p.Asp1137Gly) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 145 variantes classificadas pelo ClinVar.

29
109
7
Patogênica (20.0%)
VUS (75.2%)
Benigna (4.8%)
VARIANTES MAIS SIGNIFICATIVAS
RNF213: NM_001256071.3(RNF213):c.10947dup (p.Glu3650fs) [Likely pathogenic]
NOS3: C648R [Pathogenic]
NOS3: NOS3, IVS12, G-C, +1 [Pathogenic]
GUCY1A1: GUCY1A1, ARG593HIS (rs370478508) [Pathogenic]
RNF213: NM_001256071.3(RNF213):c.13186-22_13186-17del [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
1Fase 11
·Pré-clínico19
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença de Moyamoya

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

20 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

NCT07517354 · Family-Based Moyamoya Susceptibility and Early DetectionRecrutando
NCT06724029 · Neurosurgical Outcome NetworkRecrutando
NCT06714097 · Application of Digital Twins' Technology in Patients Who Had…Recrutando
NA
NCT06935578 · RAre, But Not aLone: a Large Italian Network to Empower the …Recrutando
NCT07144930 · Cognitive-Motor Incorporated Training and Its Relations in C…Recrutando
NA
NCT07304947 · Cardiac Index-Guided Intraoperative Hemodynamic Management i…Recrutando
NA
NCT07140731 · The Symani Restore StudyRecrutando
NA
NCT07065409 · Treatment of Moyamoya Disease With iPSC-derived ExosomesRecrutando
PHASE1
NCT01793168 · Rare Disease Patient Registry & Natural History Study - Coor…Recrutando
NCT06832839 · Study on the Mechanism of Cognitive Impairment in Patients w…Recrutando
NCT06041659 · Functional Magnetic Resonance-Based Observations of Brain Ne…Recrutando
NCT06817434 · Study on Evaluating the Effectiveness of Statins in the Trea…Recrutando
NCT05332756 · Long-term Outcomes of Conservative Management in Patients wi…Recrutando
NCT06330818 · Imaging in Moyamoya Disease - Study to Investigate Different…Recrutando
NA
NCT03546309 · Safety and Efficacy of RIC in Pediatric Moyamoya Disease Pat…Recrutando
NA
NCT05961748 · Registry of Multicenter Brain-Heart Comorbidity in ChinaRecrutando
NCT05619068 · The Evolution and Prognosis of Moyamoya DiseaseRecrutando
NCT06477107 · A Study of Cerebral Perfusion With tDCS in Chronic Hypoperfu…Por convite
NA
NCT06634004 · Biomarker-Led Optimization of Successful Surgical Outcomes i…Por convite
NCT04240119 · Angiogenic Markers in Cerebrovascular Disease (ANFIS)Por convite

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
3.103 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 3.103

#1

Mode of Birth and Stroke Risk After Childbirth Among Women With Moyamoya Disease.

JAMA network open2026 Mar 02

There is limited large-scale evidence to guide the optimal mode of birth for patients with moyamoya disease (MMD). To evaluate whether the mode of birth (cesarean vs vaginal) is associated with stroke risk after childbirth for women with MMD. This cohort study evaluated stroke outcomes up to 3 years after childbirth. A nationwide, population-based analysis was performed using data from the Health Insurance Review and Assessment Service of South Korea. Individuals with MMD from January 1, 2002, to December 31, 2023 were identified. Among 31 750 patients, those with birth-related procedure codes were selected. The study population was restricted to women aged 19 to 49 years, and those with a diagnosis of malignant neoplasm within 3 years before the index date (date of childbirth) were excluded. Data were analyzed from June 11 to September 8, 2025. Mode of birth. The primary outcome was any stroke, defined as a composite of ischemic or hemorrhagic stroke. Secondary outcomes included ischemic stroke, hemorrhagic stroke, and transient ischemic attack. Of 1683 women analyzed (mean [SD] age, 33.6 [7.8] years), 1077 (64.0%) had cesarean births, and 606 (36.0%) had vaginal births. Post partum (3 months), any stroke incidence was 63.49 and 33.33 per 1000 person-years for cesarean and vaginal births, respectively. Multivariable analyses showed no significant risk differences for any stroke by birth mode at 3 months (adjusted hazard ratio [aHR], 0.71 [95% CI, 0.26-1.97]; P = .52) or 3 years (aHR, 0.90 [95% CI, 0.55-1.47]; P = .67). A significant interaction was observed between the mode of birth and the clinical onset type of MMD for the risk of any stroke (interaction P = .04 after Bonferroni correction); the adjusted HR for vaginal vs cesarean birth was 0.10 (95% CI, 0.01-0.79) in the asymptomatic or nonvascular onset subgroup, 1.49 (95% CI, 0.73-3.03) in the ischemic onset subgroup, and 0.94 (95% CI, 0.50-1.77) in the hemorrhagic onset subgroup. Notably, stroke incidence peaked in the early postpartum period (≤6 months: 35.7 per 1000 person-years), decreased at 1 year, and thereafter remained at a similar level. In this cohort study of women with MMD, MMD itself was not found to be an absolute indication for cesarean birth; birth planning should be individualized based on obstetric factors and clinical onset type rather than routine preference for cesarean birth. In addition, vigilant monitoring and preventive strategies during the early postpartum period are warranted.

#2

Understanding stroke risk phenotypes in pediatric patients with sickle cell disease and concurrent moyamoya arteriopathy: insights from 61 cases at a single institution.

Journal of neurosurgery. Pediatrics2026 Mar 13

Children with sickle cell disease (SCD) are at risk of developing cerebral vasculopathies, increasing the risk of stroke. While some vasculopathies are medically managed, surgical revascularization might be needed in patients who also have moyamoya arteriopathy (MMA). The aim of this study was to characterize stroke timing and phenotype between children with homozygous SCD (HbSS) alone and those with HbSS and concurrent MMA. A retrospective review of clinical and radiological information for pediatric patients (age < 21 years) with HbSS and cerebrovascular sequelae at a single institution (1997-2021) was conducted. Cerebrovascular sequelae included stroke, transient ischemic attack, elevated transcranial Doppler velocities, MMA, or other cerebral vessel stenosis. Patients with HbSS and MMA (HbSS/MMA group) were compared with patients with HbSS alone (HbSS group). Sixty-one children with HbSS were included; 35 had HbSS and MMA. Thirty-one patients in the HbSS/MMA group underwent surgical revascularization. The remaining patients were medically managed with chronic transfusion, hydroxyurea, and/or stem cell transplant. The incidence of first stroke detected on surveillance imaging peaked at 4-9 years of age for the HbSS group and 3-8 years for the HbSS/MMA group (p = 0.47). Children with concurrent MMA presented more often with symptomatic strokes (p < 0.05) and were diagnosed with MMA several years after their initial stroke (median 4.4, IQR 2.0-7.8). Although the HbSS and HbSS/MMA groups had a similar window of risk, children with HbSS and MMA had a higher stroke rate per person per year (0.15 vs 0.10). Children with HbSS and concurrent MMA have increased risk of stroke during early childhood relative to children with HbSS alone. Additionally, those with HbSS and MMA are at risk of delayed diagnosis after experiencing neurological deficit from symptomatic stroke. These findings represent an opportunity to optimize stroke prevention screening, targeting children as young as 3-8 years of age.

#3

Unusual Synchronous Arbitrary-Gate Doppler Spectra Enable Intraoperative Hemodynamic Warning of Cerebral Hyperperfusion Syndrome on Moyamoya Disease.

CNS neuroscience &amp; therapeutics2026 Mar

Cerebral hyperperfusion syndrome (CHS) is a serious complication following revascularization in moyamoya disease (MMD) patients, yet reliable predictors remain scarce. This study aims to evaluate subcortical hemodynamics intraoperatively using a novel ultrasound imaging technique, synchronous arbitrary gate spectral Doppler (SAGSD), and to identify indicators associated with CHS. A total of thirty adult MMD patients undergoing revascularization were included. Intraoperative SAGSD imaging, conventional Doppler ultrasound, and indocyanine green videoangiography (ICG-VA) were performed to assess subcortical hemodynamics at multiple sites before and after anastomosis. All thirty patients underwent revascularization, and five of the six CHS patients exhibited a distinctive "mountain" sign on SAGSD, characterized by three or more discrete velocity peaks within a single cardiac cycle observed simultaneously across two or more sampling sites. The CHS patients showed a significant increase in velocity-time integral (VTI) change (median Δ + 0.48 cm [95% CI, 0.31 to 0.65], p < 0.001) post-anastomosis on SAGSD, while conventional Doppler showed no significant change in flow velocity (all p > 0.05). Notably, in CHS patients, ICG-VA showed no statistical difference in flow velocity, delay, and time to peak after anastomosis (all p > 0.05), whereas SAGSD demonstrated hemodynamic changes such as VTI (median Δ + 0.67 cm [95% CI, 0.43-0.90], p < 0.001) via Doppler spectrum. SAGSD enables highly sensitive, multi-position, and contrast-free hemodynamic evaluation of deep cerebral microvasculature. The "mountain" sign, a novel spectral morphology corroborated by quantitative VTI elevation, is a specific intraoperative biomarker strongly associated with CHS, offering a potential predictor for early intervention and improved surgical outcomes.

#4

[Detection and Management of Asymptomatic Cerebrovascular Disease].

Brain and nerve = Shinkei kenkyu no shinpo2026 Mar

Asymptomatic carotid or intracranial arterial stenosis, silent brain infarction, cerebral white matter lesions, and cerebral microbleeds are well-established predictors of stroke. When these findings are detected through brain screening programs ("brain dock"), aggressive management of vascular risk factors is warranted. In cases of severe carotid stenosis, revascularization procedures such as carotid endarterectomy or carotid artery stenting may be considered. In East Asia, including Japan, genetic predisposition appears to play a significant role. The moyamoya disease-related RNF213 p.R4810K variant has been linked to intracranial arterial stenosis, and NOTCH3 variants are associated with an increased burden of white matter disease. Closer integration of screening programs and routine clinical care is expected to further enhance the value of brain dock.

#5

[Pathophysiology and Outcome of Asymptomatic Moyamoya Disease].

Brain and nerve = Shinkei kenkyu no shinpo2026 Mar

The widespread use of non-invasive imaging techniques has increased the detection of asymptomatic Moyamoya disease. AMORE, a prospective study launched in 2012, suggests that asymptomatic cases can present with silent infarctions or hemorrhages and have a high risk of cerebrovascular events and disease progression. Thus, strict management of lifestyle-related diseases and regular follow-up imaging are essential. Antiplatelet agents should be used cautiously because of the risk of intracranial hemorrhage. The effectiveness of cerebral revascularization surgery remains unclear.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC4.019 artigos no totalmostrando 198

2026

Subtype-specific risk patterns and asymptomatic progression in moyamoya disease: angiographic biomarkers for clinical stratification.

Journal of neurosurgery
2026

Mode of Birth and Stroke Risk After Childbirth Among Women With Moyamoya Disease.

JAMA network open
2026

Understanding stroke risk phenotypes in pediatric patients with sickle cell disease and concurrent moyamoya arteriopathy: insights from 61 cases at a single institution.

Journal of neurosurgery. Pediatrics
2026

Sulcal Hyperintense Vessel Sign (Vessel Wall Magnetic Resonance Ivy Sign) in Adult Moyamoya Disease: A High-Resolution Vessel Wall Imaging Study.

Stroke (Hoboken, N.J.)
2026

Unusual Synchronous Arbitrary-Gate Doppler Spectra Enable Intraoperative Hemodynamic Warning of Cerebral Hyperperfusion Syndrome on Moyamoya Disease.

CNS neuroscience &amp; therapeutics
2026

Letter: Effects of Scalp Nerve Block on Symptomatic Cerebral Hyperperfusion Syndrome After Combined Revascularization Surgery for Moyamoya Disease.

Journal of neurosurgical anesthesiology
2026

[Detection and Management of Asymptomatic Cerebrovascular Disease].

Brain and nerve = Shinkei kenkyu no shinpo
2026

[Pathophysiology and Outcome of Asymptomatic Moyamoya Disease].

Brain and nerve = Shinkei kenkyu no shinpo
2026

Chemotherapy management of a pediatric B-ALL patient with moyamoya disease: a case report.

Frontiers in oncology
2026

Deep learning and high-resolution magnetic resonance vascular wall imaging: current challenges and future perspectives.

Frontiers in neurology
2026

Preliminary comparison of efficacy and safety between direct bypass surgery and endovascular recanalization therapy in adult ischemic moyamoya disease.

Frontiers in neurology
2026

MOdulation-Guided ENcoding (MOGEN) Scheme for Vessel-Encoded Arterial Spin Labeling.

Magnetic resonance in medicine
2026

Transient ischemic attack after bee sting unmasking Moyamoya Angiopathy.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2026

Value of MR high-resolution vessel wall imaging in the Moyamoya-like collateral vessels diseases at the base of the brain.

Medicine
2026

Moyamoya disease in Latin America: A systematic literature review with an illustrative case.

Surgical neurology international
2026

Beyond Atrial Fibrillation: A Case of Thyrotoxicosis-Associated Ischemic Stroke in a Young Patient.

Cureus
2026

Occipital Artery to Posterior Cerebral Artery Bypass for Adult Hemorrhagic Moyamoya Disease: 2-Dimensional Operative Video.

Operative neurosurgery (Hagerstown, Md.)
2026

Whole-Exome Sequencing Improves Risk Assessments of Adult Moyamoya Disease.

Journal of clinical neurology (Seoul, Korea)
2026

Genetic Biomarkers for Moyamoya Disease Beyond Angiography.

Journal of clinical neurology (Seoul, Korea)
2026

Differentially expressed circular RNA profile in hemorrhagic and ischemic moyamoya disease.

Biomedical reports
2026

Integrative GWAS and snRNA-seq Reveal a Mesenchymal-Like Endothelial Signature in Moyamoya Disease.

Stroke
2026

Neuropsychological aspects of the Moyamoya disease: A case report.

Applied neuropsychology. Child
2026

A novel superficial temporal artery patency concept of cerebral revascularization for patients with moyamoya disease: a multicenter study.

Chinese neurosurgical journal
2026

Patient perspective on large-language model responses to questions about Moyamoya.

Acta neurochirurgica
2026

How Far Can we Go? Managing Moyamoya Syndrome in a 3-Year-Old With Thalassemia Major: A Rare Pediatric Case From Nepal.

Clinical case reports
2026

Intraoperative Diabetes Insipidus as a Predictor of Postoperative Complications Following Revascularization in Moyamoya Disease: A Retrospective Cohort Study.

Current neurovascular research
2026

Moyamoya disease beyond Japan and East Asia.

British journal of neurosurgery
2026

Methodological considerations for preoperative hemorrhage risk stratification in pediatric moyamoya disease.

International journal of surgery (London, England)
2026

Non-aneurysmal Subarachnoid Hemorrhage in an Adult With Sickle Cell Anemia: A Case Report and Review of the Literature.

Cureus
2026

Unique clinical and radiological features in patients with moyamoya disease under 4 years of age: a multicenter MACINTOSH Study in Japan.

Journal of neurosurgery. Pediatrics
2026

Moyamoya Vasculopathy and Atypical Moyamoya-like Patterns: Insights into Diagnosis and Therapeutic Implications.

NeuroSci
2026

Risk Factors Influencing Disease Onset and Surgical Outcomes in Moyamoya Disease.

Journal of multidisciplinary healthcare
2026

Superficial Temporal Artery to Middle Cerebral Artery (STA-MCA) bypass: How I do it.

Acta neurochirurgica
2026

Oral Contraceptive Use and Acute Ischemic Stroke Risk in Patients with Moyamoya Disease.

NMC case report journal
2026

Delineating the Genetic Basis of RNF213-related vasculopathies: The association of PKHD1 variants with bilateral cerebral vasculopathy.

European journal of human genetics : EJHG
2026

Effects of intravenous dexmedetomidine on hemodynamic stability, inflammatory factors, and brain injury biomarkers in patients with Moyamoya disease undergoing revascularization surgery.

American journal of translational research
2026

High flow, at a higher cost? A pilot study comparing direct vs. indirect bypass for Moyamoya disease using time-driven activity-based costing.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2026

PASAformer: Cerebrovascular Disease Classification with Medical Prior-Guided Adapter and Pathology-Aware Sparse Attention.

IEEE journal of biomedical and health informatics
2026

Neuropsychological correlates of moyamoya disease: A clinical case study.

The Clinical neuropsychologist
2026

Research on the application of cerebral blood flow reconstruction technology in the surgical treatment of moyamoya disease.

Frontiers in surgery
2026

Artificial intelligence for microembolic signal detection by transcranial Doppler in ischemic stroke: a mini-review.

Frontiers in neurology
2026

Association of local collateral formation on TOF-MRA with plaque characteristics and ischemic stroke in intracranial atherosclerotic stenosis.

BMC medical imaging
2026

Angiographic outcomes after indirect revascularization in pediatric Moyamoya disease: a systematic review and Meta-analysis.

Neurosurgical review
2026

Presence of Collaterals from the Contralateral Hemisphere on Preoperative Angiogram Predicts Failure of Encephalo-Duro Arterio-Synangiosis (EDAS) in Adult Moyamoya Patients.

AJNR. American journal of neuroradiology
2026

Cortical venous redness as a semi-quantitative marker for predicting transient neurological events in adult moyamoya disease.

Neurosurgical review
2026

Clinical Translation of Ultrasound Localization Microscopy: A Narrative Review of Current Applications and Future Directions.

Ultrasound in medicine &amp; biology
2026

Increased burden of systemic hypertension among pediatric patients with moyamoya disease: a population-based analysis of prevalence and incidence.

Journal of neurosurgery. Pediatrics
2026

Thyrotoxicosis and Moyamoya Syndrome: A Fatal Intersection of Rare Disorders in a Young Patient With a Background of Hypothyroidism.

Cureus
2026

Characteristics of 3D pCASL parameters in patients with moyamoya disease and their predictive value for cognitive function after revascularization surgery.

Archives of physiology and biochemistry
2026

Single-cell transcriptomic profiling of peripheral blood mononuclear cells reveals monocyte heterogeneity in patients with Moyamoya disease.

Orphanet journal of rare diseases
2026

Preliminary analysis of long-term prognosis outcomes of modified extracranial-intracranial bypass reconstruction for adult ischemic moyamoya disease.

Scientific reports
2026

Assessment of cerebrovascular reserve using acetazolamide brain perfusion SPECT in Moyamoya disease.

Asia Oceania journal of nuclear medicine &amp; biology
2025

Preoperative local hemodynamics predict cerebral hyperperfusion syndrome after direct bypass for moyamoya disease: a quantitative CTP study based on ASPECT topography.

Frontiers in neurology
2026

The AMORE Score for Predicting the 5-Year Risk of Hemorrhagic Stroke in Asymptomatic Moyamoya Disease.

Cerebrovascular diseases (Basel, Switzerland)
2026

Outcomes of bypass surgery in asymptomatic moyamoya angiopathy: A multicenter study with propensity-score weighting.

European stroke journal
2026

Identifying a High-Risk Hemorrhagic Phenotype in Children With Moyamoya Disease.

Neurology
2026

Pediatric Hemorrhagic Moyamoya Disease: Clinical Course, Treatment, and Outcomes.

Neurology
2026

Identification and validation of CARS1 p.E712V and NF1 p.Q2002X in sporadic Moyamoya disease across 30 trio pedigrees.

NPJ genomic medicine
2026

Rare Vertebrobasilar Involvement in Moyamoya Disease: A Case Report With Long-Term Imaging Follow-Up.

Stroke
2025

Magnetic resonance vessel wall imaging is superior to MRA in assessing the extent of vascular involvement in patients with moyamoya disease.

Polish journal of radiology
2026

Deep learning reconstruction enhances 1.5T MR angiography beyond 3T in vascular visualization for Moyamoya disease.

Japanese journal of radiology
2026

Familial Moyamoya disease associated with dual RNF213 variants (R4810K and T1727M): A case report and genetic investigation.

Medicine
2025

Recovery of Intrinsic Cognitive Weakness in Successive Processing After Bypass Surgery for Pediatric Moyamoya Disease.

Stroke (Hoboken, N.J.)
2025

Persistent Periventricular Anastomosis Associated With Rebleeding After Bypass Surgery for Hemorrhagic Moyamoya Disease.

Stroke (Hoboken, N.J.)
2026

Sleep Disorders in Moyamoya Disease: Prevalence, Risk Factors, and Impact on Functional Outcomes.

Current neuropharmacology
2026

Morphological characteristics of choroidal anastomosis as predictors of subsequent rupture in adult moyamoya disease: a longitudinal study using vessel wall imaging.

Journal of neurosurgery
2025

Case Report: Relapsing systemic lupus erythematosus treated with dual rituximab and anifrolumab therapy.

Frontiers in medicine
2026

Outcomes of Bypass Surgery in Patients with Moyamoya Syndrome Secondary To Sickle Cell Disease: a Multicenter Study.

Translational stroke research
2026

Moyamoya syndrome and persistent trigeminal artery: description of a case with Trisomy 21.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

Application of Artificial Intelligence in the Diagnosis and Treatment of Moyamoya Disease: Current Status, Challenges, and Future Prospects.

The neurologist
2026

Revascularization in Pediatric Patients with Moyamoya Disease.

Turkish neurosurgery
2026

Vasospastic Angina (Coronary Spastic Angina) in the Left Main Trunk in a Patient With RNF213 p.R4810K Variant and a History of Moyamoya Disease.

Circulation journal : official journal of the Japanese Circulation Society
2026

Postoperative seizure, stroke, hemorrhage, and cerebral hyperperfusion syndrome rates in adult patients with moyamoya disease undergoing revascularization: a systematic review and proportional meta-analysis.

Neurosurgical review
2026

Short-TR Acquisition Time-of-flight MR Angiography with Deep Learning Reconstruction: Technical Feasibility and Initial Clinical Evaluation in Moyamoya Disease.

Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine
2026

Right posterior communicating artery aneurysm with multiple arterial stenoses and moyamoya disease: A case report.

The Journal of international medical research
2026

Cilostazol in a Child With Moyamoya Disease.

Journal of child neurology
2025

Treatment Options for Patients With Moyamoya Disease: A Retrospective Cohort Study.

Revista de neurologia
2026

Organoid Modeling and Single-Cell Profiling Reveal Smooth Muscle Cell Migration in Moyamoya Disease.

Communications biology
2026

Endothelial-Mesenchymal transition in cerebrovascular diseases: molecular mechanisms and promising pharmacological strategies.

Molecular biology reports
2026

Bone flap osteomyelitis following craniotomy in children: A 20-year audit.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2026

Evaluating the role of graft angle on cerebral hemodynamics following direct cerebral bypass for moyamoya disease.

PloS one
2026

The role of artificial intelligence in estimating stroke events in Moyamoya patients: A systematic review and meta-analysis of diagnostic test accuracy.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
2026

Molecular and multimodal biomarkers in Moyamoya disease: from pathogenic mechanisms to clinical translation.

European journal of medical research
2025

Post-translational modification gene signatures implicate FBXW7 in immune and vascular dysregulation of Moyamoya disease.

Frontiers in genetics
2025

Arterial spin labeling-ASPECTS and a conventional MRI-based nomogram for predicting prognosis after surgical revascularization in Moyamoya disease.

Frontiers in neurology
2025

Association between trisomy 21 and 'puff of smoke' with an unusual presentation of transient ischaemic attack.

BMJ case reports
2026

Correlation Between Contrast-Enhanced Magnetic Resonance Vessel Wall Imaging and Cerebral Hemodynamic Reserve in Moyamoya Disease.

World neurosurgery
2025

Choroid plexus enlargement correlates with cognitive dysfunction and disease progression in Moyamoya disease.

Neurosurgical review
2025

Distinct presentation of Moyamoya disease in Iran.

European journal of translational myology
2025

Recurrent Depression With Catatonic Excitement in a Patient With Moyamoya Disease: A Case Report.

The journal of ECT
2025

Distinct impact of RNF213 p.R4810K genotype on transdural collateral formation across Japanese Asian and Polish Caucasian Moyamoya patients.

Neurosurgical review
2025

Progressive occlusion of the middle cerebral artery as the main feeder in a cerebral arteriovenous malformation: A case report.

Surgical neurology international
2025

Successful Bentall Surgery in a Moyamoya Disease Patient with Intraoperative Brain Protection via IABP-Induced Pulsatile Flow and CO2 Management during Cardiopulmonary Bypass.

Surgical case reports
2025

Successful Clazosentan Therapy for Subarachnoid Hemorrhage after Coil Embolization of Ruptured Posterior Cerebral Artery Aneurysm in a Patient with Moyamoya Disease: A Case Report.

NMC case report journal
2025

Incidence of cerebral hyperperfusion syndrome following revascularization surgery in moyamoya patients: a systematic review and meta-analysis.

Neurosurgical review
2026

Emerging innovations in the management of pediatric moyamoya disease.

World journal of pediatrics : WJP
2025

Increased plasma fibronectin mirrors intimal phenotypic switching of vascular smooth muscle cells in moyamoya arteriopathy.

Scientific reports
2025

Anti-Caspr2 Encephalitis Co-occurring With Moyamoya Disease: A Pediatric Case Report and Literature Review.

Journal of child neurology
2025

When Stroke Strikes Early: Unusual Causes of Intracerebral Hemorrhage in Young Adults.

Journal of clinical medicine
2025

Contrasting Cerebral Hyperperfusion Patterns in Moyamoya Disease Versus Atherosclerotic Occlusive Cerebrovascular Disease: Insights From Day-One 99mTc-ECD SPECT After Revascularization.

Clinical nuclear medicine
2025

Advancing Prediction of Cerebral Hyperperfusion Syndrome in Moyamoya Disease:: Standardization of Definitions, Imaging Modalities, and Risk Factors for Improved Clinical Outcomes.

Clinical nuclear medicine
2026

Precision medicine in Moyamoya vasculopathy.

Current opinion in neurology
2025

Multi-omics research on moyamoya disease: current perspectives and future directions.

Nutrition &amp; metabolism
2025

Chinese expert consensus on the treatment and diagnosis of moyamoya disease and moyamoya syndrome (2024).

Stroke and vascular neurology
2025

Obstetric and anesthetic management of parturients with intracranial neurovascular abnormalities.

Journal of anesthesia
2026

ST-Elevation Myocardial Infarction in a Young Man With Moyamoya Disease.

JACC. Case reports
2025

Cerebral hemodynamics and vascular dementia: Identifying opportunities for early intervention.

The Medical journal of Malaysia
2025

MicroRNA-29b-3p promotes endothelial cell inflammation via NTRK2/PI3K/NLRP3 pathway in Moyamoya disease.

European journal of medical research
2025

Regional disparities in cerebral perfusion and brain tissue microstructure damage in adult patients with Moyamoya syndrome.

Scientific reports
2026

Characteristics of sleep disturbance in Moyamoya disease.

Sleep medicine
2025

[Aneurysms associated with moyamoya angiopathy (clinical cases)].

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
2025

[Posterior cerebral artery revascularization in Moyamoya disease using augmented reality technology: a case report and literature review].

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
2025

Spatial transcriptomics reveals TGF-β-driven endothelial-mesenchymal transition in vascular remodeling of moyamoya disease.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
2025

Risk of peripartum cerebrovascular events in women with moyamoya disease: A multicenter cohort study.

International journal of stroke : official journal of the International Stroke Society
2025

Pediatric Stroke in a United Arab Emirates (UAE) Tertiary Care Center: A Retrospective Descriptive Study.

Cureus
2025

Multimodality Imaging of Moyamoya Disease: A Practical Guide for Neuroradiologists Based on a Case Report.

Reports (MDPI)
2025

Study on Abnormal Angiogenesis in Moyamoya Disease via Mitochondrial D-Loop Methylation.

Brain and behavior
2026

Blood Pressure Management and Postoperative Stroke Risk in Pediatric Moyamoya Disease.

Pediatric neurology
2025

Moyamoya Disease in an Eight-Year-Old Female Child-A Case Report.

Clinical case reports
2026

Bioinformatic analysis and experimental validation of mitochondria-related genes as novel biomarkers for moyamoya disease.

Computational biology and chemistry
2026

Effect of encephalomyosynangiosis procedure on post stroke recovery in a permanent model of ischemic stroke.

Experimental neurology
2025

Twig-Like Middle Cerebral Artery: A Rare Cause of Pediatric Stroke That Mimics Moyamoya Disease.

Journal of child neurology
2025

Perfusion Territory Shifts in Cerebrovascular Diseases Measured by Super-Selective Arterial Spin Labeling.

Journal of neuroimaging : official journal of the American Society of Neuroimaging
2025

Indirect Revascularization for Pediatric Moyamoya Angiopathy: Insights from a Brazilian Cohort.

Journal of clinical medicine
2025

[Guidelines for the clinical management of patients with moyamoya disease and moyamoya syndrome(2025 edition)].

Zhonghua yi xue za zhi
2026

Champagne bottle neck sign predicts intracranial hemorrhage in Moyamoya disease: A long-term follow-up study.

Clinical neurology and neurosurgery
2025

A Novel Method in PET Image Reconstruction Using MRI Anatomical Priors.

IEEE transactions on radiation and plasma medical sciences
2026

Evaluation of meningeal lymphatic vessels with delayed contrast enhanced vessel-wall MRI in cerebral infarction.

Japanese journal of radiology
2025

Rogers Syndrome and Callosal Disconnection in the Setting of Moyamoya Disease.

Cureus
2025

Neurite orientation dispersion and density imaging reveals microstructural damage in moyamoya disease: a study based on tract- and gray-based spatial statistics.

BMC medical imaging
2025

[Epilepsy in Patients With Moyamoya Angiopathy].

Revista de neurologia
2025

Morning Glory Disc Anomaly With Ipsilateral Carotid Vasculopathy: MRI Characteristics and Clinical Implications.

Cureus
2026

Twig-Like Middle Cerebral Artery : Acquired Lesion Rather than Congenital Anomaly.

Journal of Korean Neurosurgical Society
2025

Moyamoya Disease: Pathophysiology, Diagnosis, and Treatment.

Deutsches Arzteblatt international
2025

Glymphatic impairment in Moyamoya disease.

Molecular and cellular neurosciences
2025

Systemic Vasculopathy Associated With Homozygous RNF213 Mutation Presenting as Peripheral Pulmonary Artery Stenosis and Coronary Vasospasm Without Moyamoya Disease: A Case Report.

Journal of Korean medical science
2025

Coil embolization via donor superficial temporal artery for de novo aneurysm associated with revascularization surgery in a patient with moyamoya disease: illustrative case.

Journal of neurosurgery. Case lessons
2025

Moyamoya disease in pediatric Down syndrome: diagnostic challenges and management strategies: a case report.

Annals of medicine and surgery (2012)
2025

Superselective Embolization of a Cavernous Sinus Dural Arteriovenous Fistula in a Patient with Moyamoya Disease.

Journal of neuroendovascular therapy
2025

The assessment of caregiver burden and associated factors on the primary family caregivers for patients with moyamoya disease: a cross-sectional study.

Frontiers in psychiatry
2025

Moyamoya Disease: Epidemiology, Clinical Characteristics, Diagnosis, Physiopathology, and Treatment.

Cerebrovascular diseases (Basel, Switzerland)
2025

Overcoming the Challenge of Distal Lenticulostriate Artery Aneurysms With Transarterial Embolization: Technical Insights, Case Series, and Literature Review.

Neurosurgery practice
2025

Quantification of High-Resolution Contrast-Enhanced T1-Weighted Vessel Wall MRI for Predicting Disease Progression in Moyamoya Disease.

Brain sciences
2025

Delayed Intracerebral Hemorrhage 15 Years After Indirect Revascularization in Moyamoya Disease: A Case Report and Review of the Literature.

Brain sciences
2025

The efficacy of the simple bypass protocol for chronic cerebral arterial occlusion and moyamoya disease.

Chinese neurosurgical journal
2025

Incidence and outcome of pediatric moyamoya disease in the Republic of Korea: A nationwide study.

International journal of stroke : official journal of the International Stroke Society
2025

The orbital grading system in pediatric moyamoya: an interrater reliability analysis of angiographic outcomes.

Journal of neurosurgery. Pediatrics
2025

Metabolic Syndrome and Risk of Moyamoya Vasculopathy and Subsequent Stroke in Young Adults.

Journal of the American Heart Association
2025

A ruptured de novo anastomotic aneurysm shortly after superficial temporal artery-to-middle cerebral artery bypass surgery in a patient with moyamoya disease: illustrative case.

Journal of neurosurgery. Case lessons
2025

Branching patterns and variations of the anterior choroidal artery: a detailed cadaveric morphometric analysis.

Neurosurgical review
2025

Efficacy of a Modified Superficial Temporal Artery-Middle Cerebral Artery Bypass Using Superficial Temporal Artery Side-Branch Donors in Adult Moyamoya Disease: A Technical Note.

Journal of clinical medicine
2025

Clinical features, treatment and long-term outcomes of hemorrhagic moyamoya disease in children: an extensive follow-up study.

Stroke and vascular neurology
2025

Blood Pressure Profile in Pediatric Moyamoya: Longitudinal Analysis and Revascularization Impact.

Pediatric neurology
2025

Chronic cerebral hypoperfusion-induced myelin loss in normal-appearing white matter correlates with cognitive decline: insights from moyamoya disease.

Alzheimer's &amp; dementia (New York, N. Y.)
2025

The unique characteristics and risk factors of enlarged perivascular spaces in pediatric moyamoya disease.

Quantitative imaging in medicine and surgery
2025

Accelerated brain age in Moyamoya disease patients: a deep learning approach and correlation with disease severity.

Frontiers in neuroscience
2025

Alkaline phosphatase predicts short-term postoperative outcome in adult patients with moyamoya disease.

Frontiers in neurology
2025

Middle Meningeal Artery Collateralization Patterns and Influencing Factors in Pediatric Moyamoya.

Cerebrovascular diseases (Basel, Switzerland)
2025

STC1 downregulation promotes ferroptosis in human brain microvascular endothelial cells: implications for moyamoya disease pathogenesis.

Neuroscience
2025

Successful coronary artery bypass grafting in a moyamoya patient with prior Encephaloduroarteriosynangiosis.

Interdisciplinary cardiovascular and thoracic surgery
2025

RNF213 c.14429G > A (p.Arg4810Lys) is associated with non-arteritic retinal artery occlusion.

Scientific reports
2026

Multiple arachnoid membrane opening to promote angiogenesis in adult patients with moyamoya disease after combined bypass surgery: a multicenter randomized controlled clinical trial.

Journal of neurosurgery
2025

Visualization of Moyamoya Vessels Using Transcranial Color-Coded Duplex Sonography: A Case Report.

Cureus
2025

Moyamoya disease: epidemiology, clinical features, pathogenesis, diagnosis and therapeutic interventions.

Molecular biomedicine
2025

Pediatric Moyamoya Disease in Nepal and Challenges in a Resource-Limited Setting: A Case Report.

Clinical case reports
2025

How I do it - extracranial-intracranial bypass surgery integrating STA-MCA anastomosis, synangiosis, MMA supply, and preservation of recipient artery perforators: the Integrated Method.

Acta neurochirurgica
2025

The Spectrum of Headaches in Moyamoya Angiopathy: From Mechanisms to Management Strategies-A Consensus Review From the NEUROVASC Working Group.

European journal of neurology
2025

Integrating machine learning for the identification of ubiquitination-associated genes in moyamoya disease.

Frontiers in neurology
2025

Moyamoya Disease in Pregnancy: A Case Report and Review of the Literature.

Cureus
2025

Identification of Biomarkers Related to the Pathogenesis and Prognosis of Pediatric Moyamoya Disease Via Cerebrospinal Fluid Proteomics.

Translational stroke research
2025

Angiographic Characteristics and Progression in A Comprehensive Nationwide European MOYAMOYA Cohort.

European journal of neurology
2025

The multifaceted role of RNF213 in oncogenesis: current insights and future research directions.

Discover oncology
2025

Hemoglobin SC Sickle Cell Disease Presenting as Acute Ischemic Stroke With Moyamoya Syndrome in an Adult: A Case Report.

Cureus
2025

Mesenchymal stem cell-derived extracellular vesicles exert Th1-mediated anti-inflammatory effects via miR-146a/NF-κB pathway: comparison with dupilumab in a mouse model of atopic dermatitis.

Stem cell research &amp; therapy
2025

Demographic, imaging and disease patterns of moyamoya angiopathy in South Auckland: an observational study from electronic health records.

Internal medicine journal
2025

Downregulation of IL-20RA in Cerebrospinal Fluid Associated with the Risk of Moyamoya Disease: A Molecular Signatures Analysis with an Inflammation Proteomics Landscape.

Journal of inflammation research
2025

A complex case of moyamoya disease mimicking vasculitis: diagnostic challenges and systemic complications in a young adult.

Radiology case reports
2025

Differentially Expressed Genes and Biological Pathways in Moyamoya Disease: A Systematic Review and Meta-analysis of Transcriptomic Studies.

Translational stroke research
2025

Genetic epidemiology of moyamoya disease and CADASIL in over 120,000 healthy Korean individuals: Insights into cerebrovascular disorders.

PloS one
2025

Effect of direct revascularization on cerebral vasodilatory reserve in the unoperated hemisphere in Moyamoya disease.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
2025

Combination of Perioperative Cilostazol and Aspirin in Pediatric Moyamoya: A Case Series.

Pediatric neurology
2025

Evaluation of Cortical Microvascularization by Preoperative Maximum Intensity Projection Method in Moyamoya Disease Reflects the Increase of Pial Arteries on the Brain Surface.

Neurologia medico-chirurgica
2025

The Falcate Artery: Its Dynamics in Vasospasm.

The Indian journal of radiology &amp; imaging
2025

Optimizing Surgical Timing to Reduce Stroke Risk in Pediatric Moyamoya Disease.

Stroke
2025

Short Stature in Moyamoya Disease: A Systematic Review of Potential Mechanisms and Clinical Outcomes.

Stroke research and treatment
2025

A thyroid storm causing strokes and unmasking moyamoya.

Radiology case reports
2025

Journal Club: Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients With Moyamoya Disease.

Neurology
2025

Moyamoya Syndrome or Moyamoya Disease? Primary CNS Vasculitis in a Child? The Importance of Nomenclature.

International journal of rheumatic diseases
2025

Moyamoya Disease and the Risk of Parkinson's Disease.

Annals of clinical and translational neurology
2025

Ultrasonographic assessment of bypass capacity after revascularization surgery in moyamoya disease: a systematic review and single-arm meta-analysis.

Acta neurochirurgica
2025

Unveiling Psychiatric Manifestations in a Case of Moyamoya Disease.

Cureus
2025

Moyamoya Syndrome in Patients With Down Syndrome and Acute Lymphoblastic Leukemia.

Pediatric blood &amp; cancer
2025

Single-Cell Transcriptome Profiling Reveals Dynamic Cell Populations and Immune Infiltration in Moyamoya Disease.

Journal of the American Heart Association
2025

The impact of anesthesia methods on early postoperative cognitive function in Moyamoya disease patients after vascular bypass surgery.

Medicine
2025

A Rare Case of Moyamoya Disease in Infancy: Complexities in Post-stroke Neurorehabilitation.

Cureus
2025

Clinical and hemodynamic outcomes of side-to-side anastomosis in superficial temporal artery-middle cerebral artery bypass for adult patients with moyamoya disease: a prospective cohort study.

Frontiers in neurology
2026

Toward Semiautomated Analysis of Cerebrovascular Reserve: Enhancing Objective Comparisons Using 99m Tc-HMPAO SPECT With Acetazolamide in Moyamoya.

Neurosurgery
2025

Symptomatic cerebral hyperperfusion after occipital artery-posterior cerebral artery bypass in a patient with moyamoya disease: illustrative case.

Journal of neurosurgery. Case lessons
Ver todos os 4.019 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença de Moyamoya.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Doença de Moyamoya

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Mode of Birth and Stroke Risk After Childbirth Among Women With Moyamoya Disease.
    JAMA network open· 2026· PMID 41870425mais citado
  2. Understanding stroke risk phenotypes in pediatric patients with sickle cell disease and concurrent moyamoya arteriopathy: insights from 61 cases at a single institution.
    Journal of neurosurgery. Pediatrics· 2026· PMID 41825074mais citado
  3. Unusual Synchronous Arbitrary-Gate Doppler Spectra Enable Intraoperative Hemodynamic Warning of Cerebral Hyperperfusion Syndrome on Moyamoya Disease.
    CNS neuroscience &amp; therapeutics· 2026· PMID 41814502mais citado
  4. [Detection and Management of Asymptomatic Cerebrovascular Disease].
    Brain and nerve = Shinkei kenkyu no shinpo· 2026· PMID 41804513mais citado
  5. [Pathophysiology and Outcome of Asymptomatic Moyamoya Disease].
    Brain and nerve = Shinkei kenkyu no shinpo· 2026· PMID 41804510mais citado
  6. Intraoperative application of FFR pressure wire and FLOW800 imaging as predictors of postoperative cerebral perfusion abnormalities in Moyamoya disease.
    Front Surg· 2026· PMID 41993793recente
  7. Anesthetic Management of a Patient With Factor XIII Deficiency Undergoing Encephaloduroarteriosynangiosis (EDAS): A Case Report and Literature Review.
    Cureus· 2026· PMID 41993762recente
  8. Iterative delay correction improves breath-hold cerebrovascular reactivity mapping in clinical populations.
    bioRxiv· 2026· PMID 41993363recente
  9. Severe stenosis of major intracranial arteries: an important risk factor for infarction complications after combined revascularization in adult patients with ischemic moyamoya disease.
    Chin Neurosurg J· 2026· PMID 41981694recente
  10. Ferulic acid promotes proliferation and angiogenesis of cerebral microvascular endothelial cells in Moyamoya disease via the SIRT1/HIF-1α/VEGF-A axis.
    Brain Res Bull· 2026· PMID 41980628recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2573(Orphanet)
  2. MONDO:0016820(MONDO)
  3. GARD:7064(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q1951267(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Doença de Moyamoya
Compêndio · Raras BR

Doença de Moyamoya

ORPHA:2573 · MONDO:0016820
Prevalência
1-9 / 100 000
Herança
Autosomal dominant, Autosomal recessive, Multigenic/multifactorial, X-linked recessive
CID-10
I67.5 · Doença de Moyamoya
CID-11
Ensaios
24 ativos
Início
All ages
Prevalência
6.2 (Japan)
MedGen
UMLS
C0026654
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades